Published online Nov 18, 2025. doi: 10.5312/wjo.v16.i11.111242
Revised: August 10, 2025
Accepted: October 20, 2025
Published online: November 18, 2025
Processing time: 140 Days and 23.4 Hours
In this article, we make a comment on the recent article by Sun et al, focusing on the advances of neutrophil extracellular traps (NETs) formation in common osteoarticular diseases. Neutrophils are the first line to eliminate invading pathogens including fungal and bacterial infections via releasing hydrolytic enzymes and reactive oxygen species. Besides, neutrophils will accumulate at the inflammatory site and release NETs, which are composed of histones, DNA and granular proteins. Traumatic heterotopic ossification (THO) was generally be
Core Tip: The role of neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of heterotopic ossification (HO) has been extensively studied. Neutrophils accelerate the progression of HO through multiple molecular mechanisms, including upregulating the expression levels of bone morphogenetic protein, interleukin-1α and transforming growth factor β, leading to osteogenic differentiation of mesenchymal stem cells. Meanwhile, the presence of NETs causes the local area to remain in persistent inflammation, which provides a suitable microenvironment for bone formation. By transplanting umbilical cord mesenchymal stem cells and applying batroxobin, QBM076, necrosulfonamide and peptidylarginine deaminase 4 to target neutrophils or NETs, which can play a positive role in the treatment of HO. The therapeutic potential of NETs for addressing HO warrants further investigation in future studies.
